SCHW vs SRPT · P/E 19, rev $13.55B vs rev $1.13B
Charles Schwab Corp (SCHW) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
SCHW currently screens at market cap $164.37B and trailing P/E 18.8. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the SCHW and SRPT stock pages for the full models.
Not investment advice.